Axogen, Inc.
AXGN- Exchange
- Nasdaq
- Industry
- Electromedical & Electrotherapeutic Apparatus
- SEC CIK
- 0000805928
In the last 90 days, Axogen, Inc. insiders filed 0 open-market purchases and 1 sale; 255 institutions reported holding it in 13F filings for Q2 2026, worth $2.43B in total; no superinvestor holds it.
Key figures
- Market capClose on Nov 9, 2026
- $3.02B
- Insider buysOpen market, last 90 days
- 0
- Insider sellsLast 90 days, $173.9K in total
- 1
- 13F holdersQ2 2026, +34 vs. previous quarter
- 255
- 13F valueReported value at the end of Q2 2026
- $2.43B
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Financials
See financial statementsFrom SEC filings, in USD.
- Revenue, FY2025
- $225.2M
- +20.2% year over year
- Net income, FY2025
- -$15.7M
- No comparable prior period
- Free cash flow, FY2025
- -$2.93M
- −304.5% year over year
- Revenue, Q3 FY2026
- $75.8M
- +26.2% year over year
Revenue flow, FY2025
Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue.
Net loss for FY2025: $15.7M (7.0% of revenue).
Short interest
See short dataFrom FINRA, settlement date Oct 15, 2026.
- Short interest
- 5.12M
- Shares sold short
- Change
- +426.3K
- +9.1% vs. previous
- Days to cover
- 3.02
- At average daily volume
Superinvestors holding AXGN, Q2 2026
Go to the superinvestors tabNo superinvestor reported holding AXGN at the end of Q2 2026.
Latest insider trades
See all insider tradesOpen-market purchases and sales by Axogen, Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 4, 2026 (view filing)4:08 PM ET | Sep 2 | 2 days | Tyndall Joseph A.Director | SSale | −3.50K | $49.70 | −$173.9K | −24.7%10.7K after | 10b5-1 |
| Aug 12, 2026 (view filing)4:13 PM ET | Aug 10 | 2 days | Began Marc AEVP & General Counsel | SSale | −67.5K | $47.35 | −$3.20M | −57.4%50.1K after | 10b5-1 |
| Aug 12, 2026 (view filing)4:12 PM ET | Aug 11 | 1 day | Wendell Amy McBrideDirector | SSale | −13.4K | $48.42 | −$646.6K | −11.0%108.0K after | 10b5-1 |
| Aug 11, 2026 (view filing)4:15 PM ET | Aug 7 | 4 days | Weiler Kathy JohnsonDirector | SSale | −14.2K | $45.30 | −$641.0K | −100.0%0 after | 10b5-1 |
| May 12, 2026 (view filing) | May 8 | 4 days | Wendell Amy McBrideDirector | SSale | −1.65K | $42.60 | −$70.2K | −1.7%93.8K after | |
| May 8, 2026 (view filing) | May 7 | 1 day | Johnson JohnDirector | SSale | −11.1K | $43.26 | −$478.0K | −100.0%0 after | |
| May 8, 2026 (view filing) | May 7 | 1 day | Weiler Kathy JohnsonDirector | SSale | −16.3K | $44.09 | −$720.6K | −100.0%0 after | |
| May 8, 2026 (view filing) | May 7 | 1 day | Kemp JensChief Marketing Officer | SSale | −4.00K | $43.44 | −$173.8K | −5.2%72.5K after | |
| May 8, 2026 (view filing) | May 7 | 1 day | Hartley Lindsey MarieCFO | SSale | −1.05K | $43.67 | −$45.9K | −1.6%65.1K after | 2 lots |
| May 8, 2026 (view filing) | May 7 | 1 day | Quackenbush DorisSales VP | SSale | −3.88K | $43.51 | −$168.7K | −4.0%92.4K after |
Top 10 13F holders, Q2 2026
See all 255 holdersThe largest institutional positions in Axogen, Inc. at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BlackRock, Inc. | 4,419,208 | $204.1M | 0.00% | +548,357+14.2% | Added |
| First Light Asset Management, LLC | 2,748,361 | $126.9M | 7.72% | −1,254,407−31.3% | Reduced |
| Morgan Stanley | 2,747,924 | $126.9M | 0.01% | −375,058−12.0% | Reduced |
| Vanguard Capital Management LLC | 2,257,948 | $104.3M | 0.00% | −33,615−1.5% | Reduced |
| Polar Capital Holdings Plc | 1,500,822 | $69.3M | 0.20% | 00.0% | Unchanged |
| Artemis Investment Management LLP | 1,396,792 | $64.5M | 0.58% | +1,046,904+299.2% | Added |
| Wellington Management Group LLP | 1,391,654 | $64.3M | 0.01% | +427,089+44.3% | Added |
| Geode Capital Management, LLC | 1,375,240 | $63.5M | 0.00% | +155,099+12.7% | Added |
| Citadel Advisors LLC | 1,360,831 | $62.9M | 0.04% | +1,115,777+455.3% | Added |
| Wasatch Advisors Inc | 1,295,949 | $59.9M | 0.39% | −561,401−30.2% | Reduced |
Holders of 5% or more of AXGN
See all 3 holders and filingsHolders whose latest Schedule 13D or 13G filing reports 5% or more of Axogen, Inc..
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| First Light Asset Management, LLC | 13G/A | 7.58%4.07M shares | +0.78 ppfrom 6.80% | Feb 16, 20218 filings | Aug 14, 2026 | SEC |
| Divisadero Street Capital Management, LP | 13G | 6.80%3.98M shares | New | Oct 2, 20261 filing | Oct 2, 2026 | SEC |
| Morgan Stanley | 13G/A | 5.30%2.33M shares | – | Feb 12, 20242 filings | Feb 3, 2025 | SEC |
Politician trades
All politician trades in AXGN1 member of Congress reported 2 trades in Axogen, Inc. since 2020. Newest filings:
| Filed | Politician | Type | Amount |
|---|---|---|---|
| Apr 27, 2020 |  Donna E. Shalala House · FL | Buy | $1K-$15K |
| Apr 27, 2020 | Donna E. Shalala House · FL | Sell | $1K-$15K |
House · FL · Apr 27, 2020
Buy$1K-$15K
House · FL · Apr 27, 2020
Sell$1K-$15K